• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MabVax Therapeutics Holdings Inc

TK8N:GR

Ticker Delisted

As of 02:16:13 ET on 08/21/2014.

Snapshot for MabVax Therapeutics Holdings Inc (TK8N)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 0.554 - 1.448 1-Yr Rtn: -

Stock Chart for TK8N

No chart data available.
  • TK8N:GR 0.571
  • 1D
  • 1M
  • 1Y
0.000
Interactive TK8N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TK8N

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TK8N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TK8N

MabVax Therapeutics Holdings Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs to treat serious diseases. The Company's most advanced product development programs are for the treatment of cancer and diabetes.

J David HansenPresident/CEOGregory P HansonChief Financial Officer
Philip O LivingstonChief Science OfficerWolfgang W ScholzVP:Antibody Discovery
More Company Profile & Key Executives for TK8N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil